Updated Jul 16, 2026
Lu Peng has filed 10 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $2.24M.
Lu Peng is associated with Pharvaris N.V., a biopharmaceutical company focused on developing treatments for hereditary angioedema. Specific details about his role and contributions are not widely documented.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-14 | PHVS | Pharvaris N.V. | F — Tax withholding / forfeiture | 117 | $35.07 | $4K |
| 2026-07-14 | PHVS | Pharvaris N.V. | F — Tax withholding / forfeiture | 109 | $35.07 | $4K |
| 2026-06-29 | PHVS | Pharvaris N.V. | S — Open-market sale | 14.7K | $34.00 | $500K |
| 2026-06-29 | PHVS | Pharvaris N.V. | M — Option exercise | 14.7K | $2.59 | $38K |
| 2026-06-29 | PHVS | Pharvaris N.V. | S — Open-market sale | 3.4K | $35.09 | $119K |
| 2026-06-29 | PHVS | Pharvaris N.V. | S — Open-market sale | 11.6K | $34.45 | $400K |
| 2026-06-29 | PHVS | Pharvaris N.V. | M — Option exercise | 15.0K | $2.59 | $39K |
| 2026-06-23 | PHVS | Pharvaris N.V. | S — Open-market sale | 300 | $34.00 | $10K |
| 2026-06-23 | PHVS | Pharvaris N.V. | M — Option exercise | 300 | $2.59 | $777 |
| 2026-06-16 | PHVS | Pharvaris N.V. | F — Tax withholding / forfeiture | 117 | $32.20 | $4K |
| 2026-06-15 | PHVS | Pharvaris N.V. | F — Tax withholding / forfeiture | 109 | $31.51 | $3K |
| 2026-05-13 | PHVS | Pharvaris N.V. | F — Tax withholding / forfeiture | 117 | $29.95 | $4K |
| 2026-05-13 | PHVS | Pharvaris N.V. | F — Tax withholding / forfeiture | 109 | $30.09 | $3K |
| 2026-05-05 | PHVS | Pharvaris N.V. | S — Open-market sale | 143 | $31.00 | $4K |
| 2026-05-05 | PHVS | Pharvaris N.V. | S — Open-market sale | 14.0K | $30.16 | $423K |
| 2026-05-05 | PHVS | Pharvaris N.V. | M — Option exercise | 14.2K | $2.59 | $37K |
| 2026-05-01 | PHVS | Pharvaris N.V. | S — Open-market sale | 15.0K | $30.24 | $454K |
| 2026-05-01 | PHVS | Pharvaris N.V. | M — Option exercise | 15.0K | $2.59 | $39K |
| 2026-05-01 | PHVS | Pharvaris N.V. | S — Open-market sale | 3.7K | $30.06 | $112K |
| 2026-05-01 | PHVS | Pharvaris N.V. | M — Option exercise | 3.7K | $2.59 | $10K |
Lu Peng is associated with Pharvaris N.V., a biopharmaceutical company focused on developing treatments for hereditary angioedema. Specific details about his role and contributions are not widely documented.…
10 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 10 open-market sales ($2.24M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lu Peng profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.